Coherus Oncology Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus Oncology Inc
NASDAQ:CHRS
|
US |
|
CK Hutchison Holdings Ltd
F:2CK
|
HK |
|
Pro-Dex Inc
F:PDXN
|
US |
|
Kintor Pharmaceutical Ltd
HKEX:9939
|
CN |
|
G
|
Golden Agri-Resources Ltd
XMUN:4G3A
|
SG |
|
E
|
Evercore Inc
BMV:EVR
|
US |
|
S
|
Soosan INT Co Ltd
KOSDAQ:050960
|
KR |
|
W
|
WW Grainger Inc
DUS:GWW
|
US |
|
Shibaura Machine Co Ltd
TSE:6104
|
JP |
|
Bone Biologics Corp
NASDAQ:BBLG
|
US |
|
Prosegur Compania de Seguridad SA
F:PRHA
|
ES |
|
E
|
EDP Renovaveis SA
SWB:EDW
|
ES |
|
D
|
Deutsche Boerse AG
OTC:DBOEF
|
DE |
|
J
|
J J Finance Corporation Ltd
BSE:523062
|
IN |
|
W
|
Wolters Kluwer NV
XHAM:WOSB
|
NL |
|
Iberdrola SA
F:IBE5
|
ES |
|
Ariston Holding NV
F:E0E
|
IT |
|
Seven & i Holdings Co Ltd
F:S6MA
|
JP |
|
Ubisoft Entertainment SA
PAR:UBI
|
FR |
|
Datadog Inc (Pre-Reincorporation)
NASDAQ:DDOG
|
US |
|
Howa Machinery Ltd
TSE:6203
|
JP |
|
MOBA Network AB
STO:MOBA
|
SE |
Bankruptcy Probability
Coherus Oncology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Coherus Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Coherus Oncology Inc
NASDAQ:CHRS
|
179.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Coherus Oncology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Coherus Oncology Inc has total debt of 51.8m USD. This includes both short-term (0 USD) and long-term (51.8m USD) debt.
You can find a full breakdown on its Balance Sheet.